Professor Cyrus Cooper OBE, DL, FMedSci
Cyrus Cooper is Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Unit; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Epidemiology at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.
He leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. His key research contributions have been: 1) discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood; 2) demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood; 3) characterisation of the definition and incidence rates of vertebral fractures; 4) leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture.
He is President-Elect of the International Osteoporosis Foundation; Chair of the BHF Project Grants Committee; an NIHR Senior Investigator; and Associate Editor of Osteoporosis International. He has previously served as Chairman of the MRC Population Health Sciences Research Network; Chairman of the National Osteoporosis Society of Great Britain; past-President of the Bone Research Society of Great Britain; and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups. He has published extensively (over 850 research papers; hi=119) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass. In 2015, he was awarded an OBE for services to medical research.
Professor Manuel Montero-Odasso, MD, PhD, FRCPC
Manuel Montero-Odasso, MD (University of Buenos Aires, Argentina), PhD, (University of Buenos Aires, Argentina), Postdoctoral Fellowship (McGill University, Canada), FRCPC (Internal Medicine and Geriatric Medicine, Royal College, Canada) is currently Associate Professor of Medicine, Epidemiology and Biostatistics at the University of Western Ontario, Canada and Director of the “Gait and Brain Lab” at Parkwood Institute, London, Ontario.
He leads the Gait and Brain Health Program at Parkwood Institute, with the goal of understanding the mechanisms and potential treatment of age-related mobility and cognitive decline. He focuses on gait performance research as methodology to early detect and future prevent the development of frailty, falls, and dementia in older people. He has pioneered clinical trials applying the novel approach of “improving cognition to improve mobility” and the use of “motor biomarkers” to predict progression to dementia. He is team leader in the Canadian Consortium on Neurodegeneration in Aging, Canada’s dementia research strategy.
Professor Montero-Odasso has established a successful research program while remaining an active clinician. His research has received continued peer-reviewed federal funding, has been published in high-impact journals, and has received several accolades including the American Geriatrics Society Investigator Award, the Schulich Clinician Scientist Award, the Premier of Ontario Excellence Research Award, and the CIHR New Investigator Award. He serves as editorial board member of ageing journals including Journal of Gerontology Medical Sciences, Geriatrics, and Journal of Alzheimer’s Disease. He has been invited to give more than 65 international presentations as a guest speaker.
Professor Matteo Cesari
Professor Matteo Cesari is Director of the Geriatric Unit at the Fondazione Ca' Granda-Ospedale Maggiore Policlinico (Milan, Italy) and Professor of Geriatrics at the University of Milan (Milan, Italy). His research expertise is in the screening, assessment and management of the frailty condition to prevent the disabling cascade. Prof. Cesari has been serving as consultant to the World Health Organization in the development of recommendations for healthy ageing and integrated care for older people. He is the coordinator of the European Union Geriatric Medicine Society (EUGMS) Special Interest Group on ‘Frailty in older persons’, Editor-in-Chief of the Journal of Frailty & Ageing, and Associate Editor of the Journal of Gerontology Medical Sciences. He is a member of the International Consensus Committee on Frailty.
Dr Olga Theou
Dr. Theou is a gerokinesiologist and an Assistant Professor of Medicine at Dalhousie University, Nova Scotia, Canada. She is also an Affiliated Scientist of Geriatric Medicine with the Nova Scotia Health Authority and an Adjunct Senior Lecturer of Medicine with the University of Adelaide in Australia. She has extensive experience in clinical and epidemiological frailty and in mobility/physical activity assessments and prescription, in both community and clinical settings. Dr Theou is collaborating with the CRE researchers in frailty, physical activity, mobility and epidemiological research and she is playing a pivotal role on the mentorship of junior centre researchers.
Dr Paul Gregorevic
Dr Gregorevic gained his PhD from the University of Melbourne Department of Physiology in 2001. He subsequently trained as a postdoctoral research fellow within the University of Washington Department of Neurology, Seattle USA, where he acquired expertise in molecular biology and the design of recombinant viral vectors as gene delivery technologies for studying and treating muscle diseases. In 2008, Dr Gregorevic relocated his research program to the Baker Heart and Diabetes Institute, Melbourne, where he is Head of the Laboratory for Muscle Biology and Therapeutics Development, and Director of the Recombinant Viral Vector Core. His research interests focus on elucidating the mechanisms underlying the development and regulation of the skeletal muscle phenotype, and the development of novel therapeutic interventions to combat loss of muscle function associated with heritable and acquired diseases and the aging process.
Dr Gregorevic has authored numerous papers, reviews and book chapters concerning the mechanisms of skeletal muscle function and adaptation, neuromuscular disorders, and intervention strategies for their treatment. He has served as an elected member of the Executive Committee of the Australian Gene Therapy Society since 2009.
Associate Professor Debra Waters
Associate Professor Waters is the Director of Gerontology Research at the University of Otago in Dunedin New Zealand. This is a joint appointment between the Department of Medicine and School of Physiotherapy. She is also the Director of the University of Otago Collaboration of Ageing Research Excellence (CARE) research theme; Deputy-Director of the Ageing Well National Science Challenge and Vice President of the New Zealand Association of Gerontology.
She began research on sarcopenia and sarcopenic-obesity in the 1990 as the co-director of the New Mexico Ageing Process study in Albuquerque, New Mexico. She immigrated to New Zealand in 2005 and since then has been involved with testing safe and effective life-style interventions for frail obese elders, effective community-based interventions for pre-frail older adults, and peer-led models of community falls prevention.
Associate Professor Dina LoGiudice
Associate Professor Dina LoGiudice is a Consultant Physician in Aged Care, at Royal Park campus Melbourne Health, and visiting Geriatrician at the Victorian Aboriginal Health Service and Aboriginal Community Elders Service in Melbourne. Dina is a clinical researcher and has been awarded NHMRC funding since 2003 to address the assessment, prevalence and unmet needs of older Aboriginal and Torres Strait Islander people with dementia and other common conditions of the aged, particularly those living in remote and regional areas of Australia. This work has extended to collaborations in a number of states and more recently with First Nation Canadians. Her other interests include cross cultural assessment of older people and best practice of dementia care in hospitals.